Competing risks of death in younger and older postmenopausal breast cancer patients

AIM: To show a new paradigm of simultaneously testing whether breast cancer therapies impact other causes of death. METHODS: MA.14 allocated 667 postmenopausal women to 5 years of tamoxifen 20 mg/daily ± 2 years of octreotide 90 mg, given by depot intramuscular injections monthly. Event-free surviva...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Clin Oncol
Main Authors: Chapman, Judy-Anne W, Pritchard, Kathleen I, Goss, Paul E, Ingle, James N, Muss, Hyman B, Dent, Susan F, Vandenberg, Ted A, Findlay, Brian, Gelmon, Karen A, Wilson, Carolyn F, Shepherd, Lois E, Pollak, Michael N
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2014
Assuntos:
Retrospective Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259936/
https://ncbi.nlm.nih.gov/pubmed/25493245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v5.i5.1088
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados